Skip to main content
Premium Trial:

Request an Annual Quote

Growing Quickly

China's biotech hub, dubbed Pharma Valley, is experiencing explosive growth, according to Stat News, which likens the region to Cambridge's Kendall Square.

It notes that more than two dozen drug companies have opened there in the past two years — with more than 500 there in total. In addition, it says two new subway stops have opened there recently and it's where about a third of drugs approved by the China National Medical Products Administration were developed.

According to Stat News, this growth is being driven by a combination of government and private investment, the return of researchers from abroad, and the training of local talent. The Chinese government, it says, spent $254 billion last year on research and development and has used programs like the Thousand Talents Plan to lure back Chinese researchers from abroad, and returnees have brought new business model ideas with them.

"Many [of our staff] are coming back to seek a bigger impact in the field, to lead a larger team, to have more decision-making power," Jingsong Wang, CEO and founder of Harbour BioMed, a Pharma Valley firm, says of returning researchers. "To be part of the driving force for the industry."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.